History
  • No items yet
midpage
Embrex, Inc. v. Service Engineering Corp. And Edward G. Bounds, Jr.
216 F.3d 1343
Fed. Cir.
2000
Check Treatment
Docket

*1 however, accepted First explana- Union’s

tion of the disparity: de Gorter had EMBREX, INC., Plaintiff-Appellee, informed himself of policy’s the insurance terms the interval deposi- his between

tion and affidavit. This is a plausible ex- SERVICE ENGINEERING CORP. planation, say and we cannot that its ac- Bounds, Jr., Edward G. ceptance by the bankruptcy and district Defendants-Appellants. courts anwas abuse of In discretion. event, de Gorter’s familiarity was based No. 99-1064. only on record, other materials so it United Court of Appeals, is difficult to States any prejudice see whence have would come. Federal Circuit. June

D. Class Certification After determining that none

Telfair’s merit, underlying claims had

bankruptcy court came to the ineluctable

conclusion that there were no claims to

certify as a class action lawsuit.19 It was

within the court’s discretion to consider

the merits of the claims their amen before

ability to class certification. Cowen v. Texas,

Bank Unitеd 70 F.3d (7th Cir.1995); Schock, Wright v. (9th Cir.1984); 543-44 Katz v. Carte (3d Corp.,

Blanche Cir.

1974) (en banc). With no meritorious

claims, certification of those claims as

class action is moot. agree Because we bankruptcy

with the courts’ district

disposition claims, of the merits of Telfair’s

we also affirm the denial of the motion for

class certification.

III. CONCLUSION

For reasons, the foregoing we AFFIRM

the district court’s decision affirming the

bankruptcy in all respects. bankruptcy

19. The representative, also denied Mrs. Tel- appeal but she does not fair’s motion for class on the certification decision. ground that sufficiently her claims were not *3 Myers, D. Myers,

James Bigel, Sibley & Sajovec, P.A., of Raleigh, Carolina, North argued plaintiff-appellee. for With him on were brief Robert W. Glatz and D. Ayers. Randal Jacobson, Harvey B. Jr. and Michael R. Jacobson, Price, Slobasky, Holman & Stern, PLLC, DC, of Washington, argued for ‍​‌‌​‌​‌​​​‌‌‌‌‌​‌‌​‌​‌​​​‌​‌‌​‌‌​‌​​​​​​​​‌‌‌​‌​‍defendants-appellants. LOURIE, CLEVENGER,

Before RADER, Judges. Circuit Opinion for the court PER filed CURIAM. Circuit Judge RADER concurs.

PER CURIAM.

The United Statеs District Court for the Eastern District of North Carolina award- Embrex, (Embrex) ed Inc. damages for Service Engineering Corporation’s and SEC’s) Edward Bounds’ (collectively, in- fringement 4,458,630 of No. Patent (’630 patent), including damages, direct competence immunologic developed has willfulness, attor- treble injected vaccine said and wherein finding. case exceptional under ney fees by either region defined within motions denied court also The trial (JMOL) yolk sac. amnion Lawof a Matter as Judgment trial, to overturn sought which a new 9,11.26-34. col. patent, ’630 Because jury verdicts. its license claims, obtaining Upon construing the err did machines designing began Embrex patent, could that a reasonable concluding large method willfulness, claimed perform infringement, find After farms. chicken fees, industrial attorney scale awarding and in at- products, dis- Embrex’s learning because affirms-in-part. *4 using its in Embrex interest direct to erroneously tempted awarded trict eggs transferring sup- automatically to for proper evidence device without hatching to that flats award, vacates egg-supporting the from port way of thе proceed- quarters three for further about trays remands and award also period. SEC the incubation through ings. manu- in interest its to Embrex expressed ma- ovo injection in Embrex’s facturing I. SEC’s advances. rebuffed Embrex chines. companies other two then contacted of SEC licensee exclusive is the Embrex design around collaborating to about United States from the patent the ’630 and sued Embrex SEC patent. AAct. the ’630 Bayh-Dole the under Government of infringement for Agri- of collaborators Department the U.S. its at scientist in technology. litigation That resulted patent. patented the ’630 developed the culture of a and dismissal agreement, for inocu- claims methods patent a settlement ’630 injecting by suit. against disease lating the birds egg the region of specified a into vaccines its history, continued SEC Despite this appli- hatching. In its commercial before injection ma- ovo to build attempts immunizes cation, invention the claimed device, prototype developed a SEC chine. ovo, ie., are they while still chickens two scientists the services engaged and re- Thus, method the сlaimed egg. the injecting possibility the investigate to will succumb chickens risk duces the that cov- region the embryos outside chicken an entire often infect to infections Vergil Dr. claims. patent by the ’630 ered an advance represents This method flock. be embryos could that the suggested Davis inoculat- method, which prior art over the the into vaccine by injecting inoculated the leaving hatching, days after ed several (CAS), egg of the part a sac chorioallantoic patent con- The ’630 unprotected. chicks Mr. claims. in the ’630 mentioned not claims, jury the found 12 which tains 13 to experimented Davis Dr. Bounds 1 of the Claim infringed. had SEC the target they could whether determine representative: ink several into injecting India by CAS controlling an immun- 1. A method inject- difficulty of the To address eggs. bacterial, viral, mi- or disease izable a CAS, Bounds devised Mr. into the ing com- species in an avian origin crobial into inject predeter- reliably stand to test effective a vaccine prising injecting egg. of the shell beneath the depths mined said disease immunity against inducing Rosenberger, Dr. retained also SEC embryo of embodying egg into University of Delaware. at professor injection said species, avian wherein said stand, Rosenberger test Dr. gave SEC during the final quarter of is made tests several performed which he embryo with whereby the period incubation practicability injection by reapplying the district determine the court’s standard. injected India These tests Applied Corp. into CAS. Med. Resources v. U.S. eggs and vaccine into others. ink into some Surgical Corp., F.3d target ink sought The India tests (Fed.Cir.1998). Thus, CAS, sought the vaccine whereas tests prevail appeal, SEC must show that on the effectiveness of the inocula- evaluate evidence does support substantial record, to the According tions. trial jury’s findings factual Rosenberger inject- tests showed that the in applying erred the law. See id. little embryos immunity, ed received injections penetrated beyond most may A district court overturn a amnion/yolk and into the sac—-areas CAS jury’s verdict on a motion for only JMOL by patent. covered if, record, upon the trial reasonable could not have reached that verdict. See рreparing prototype per- While Corp. Computervision Perkin-Elmer tests, forming began soliciting orders Corp., USPQ 669, injection Specifically, device. for its ovo (Fed.Cir.1984). This court considers alleges Embrex that SEC offered to sell the record light evidence most fa to Hudson Foods in the its machines *5 Embrex, vorable to all drawing reasonable Canada, in effectively and Courvoir Dufo inferences in its favor. Accordingly, this depriving Embrex of the sales. jiffy’s credibility court will not disturb the Upon learning testing of SEC’s and its determinations or substitute its resolutions attempts market thе to nascent ovo of conflicting evidence for those of the device, injection again Embrex sued SEC. Med., jury. Applied 147 F.3d at 1376- alleged infringement .suit willful Embrex’s 77. patent, of the ’680 breach of the settlement 43(a) agreement, and violation of section A.

the Lanham Act. The a district court held jury jury trial on each issue. The re- This court reviews the district a turned verdict favorable Embrex on pat court’s claim construction of the ’630 contract, infringement, breach of and will- Georgia-Pa ent without deference. See jury fulness. the returned a Co., Corp. Gyрsum v. United States cific alleged verdict favor of SEC on the 1322, 1330, 1590, USPQ2d 195 F.3d 52 In response Lanham Act violation. (Fed.Cir.1999). 1597 “In claim construc motions, post-trial the district court denied tion the words of the claims are construed JMOL, SEC’s motion for and awarded independent product, of the ‍​‌‌​‌​‌​​​‌‌‌‌‌​‌‌​‌​‌​​​‌​‌‌​‌‌​‌​​​​​​​​‌‌‌​‌​‍accused attorney Embrex treble fees light specification, prosecution of the the agree- under the terms of the settlement history, prior and the art.... con [T]he §§ ment as well as under 35 U.S.C. 284 simply way struction of claims is a (1994). The district and 285 court also terse, elaborating normаlly the claim lan granted summary judgment Embrex’s mo- guage[] order to understand and ex tion on SEC’s defense Embrex did standing plain, change, scope for but not to the of the have sue Genentech, Inc., of the ’630 because its license from Scripps claims.” Clinic v. government Bayh- the the violated (Fed.Cir.1991) (internal

Dole Act. quotations omitted).

II. independent claim preamble The controlling im 1 recites a method “for an This court reviews species ... ruling court’s after a verdict munizable an avian JMOL disease period, quarter the final incubation This lan- steps].” comprising [several conditiоns, the em- and ... these [u]nder to determine on this calls guage Id. at col. favorably respond.” bryo will dis- “controlling immunizable whether description Similarly, 11.2-6. detailed pop- anof entire inoculation requires ease” explains: “A 1-inch needle of the invention immunization effective ulation of birds and of the fully inserted from the center when birds. The of treated percentage high of a shell, the out- penetrate will large end simply 1 to de- claim read district court enclosing inner shell membranes er and method, the claimed purpose of scribe the cell, Depending the amnion. the air by preventing a disease namely to control development and precise stage of on the in individual the disease managing embryo, a needle of position of the birds. fluid either in the will terminate length supports the of the claims language itself.” Id. chick or in the chick above the The claims interpretation. district court’s instances, 3,11. In these at col. 51-58. a sin- immunizing process chick, describe the single egg, a inventor refers to example, claim calls Thus, sup- For also gle egg. injection. spеcification egg ... em- interpretation into “injecting ports a vaccine the district court’s in- that is single egg ... wherein said of a is all embryo injection bodying the use of the required by the claims. While quarter final jection during made preclude a word does not singular form of embryo period whereby incubation plural, see meaning which includes compe- immunologic developed has Co., Mfg. Elkay Mfg. Co. v. Ebco. With col. 11. patent, ’630 28-33. tence.” (Fed.Cir. 973, 977, USPQ2d process claim calls language, 1999), singular descriptions of the these of an individual involving immunization *6 without injеctions eggs, into individual popu- process than a for entire egg, rather more, only not limit the to cover claims do of lations birds. entire flock of birds. of an inoculations per reading a rule that Logic precludes speak also of a “vaccine The claims encompass plu the usage mits to singular Id. at inducing immunity.” effective for plural meaning. require ral to instead the 9, phrase This does not col. 11.28-29. all the method be effective for require that descriptions In the of individ- to addition of birds. percentage description birds or also processes, threshold the written ual context, modifies efficacy per- In the word “effective” tests reports the results of “vaccine,” multiple not the meth These re- the claimed formed animals. word however, requires no not limit the claims ports, a whole. The claim do od as populations processes performed only on more than effective to inoculate a vaccine reliability, biological tests Thus, of birds. For the district an individual chick. study many of generally groups demand of part this of the correсtly construed reproduci- to ensure accurate and animals in require only claim to that vaccine in the Reporting such data ble results. effective, but not jected is known to be description operate not written does egg actually into an every that inoculation In import a limitation into the claims. immunity. confers sum, only the claims do cover not of birds. The of entire flocks inoculation description accompa The written correctly construed this district court supports also trial nying the claims claim. of the court’s construction claims. im specification repeatedly refers to the B. example, single eggs.

munization of For fact, question summary Infringement “[I]t of the invention a states: findings of which are substantial injected during that accorded egg is essential be

1349 Foods, inquiry,’ inquiry on review. See scientific when that deference has Kraft definite, Co., cognizable, and not Trading 203 insubstantial Inc. v. International 1362, 1370, purposes”) (superseded commercial on oth- USPQ2d 53 1817 F.3d 271(e) (1994)). § grounds by er 35 U.S.C. (Fed.Cir.2000). denying In motion Roche, In this court considered whether JMOL, reviewed patented “the limited usе of a drug for evidence, jury’s verdict for substantial and testing investigation strictly related to reapplies the same standard on this court FDA drug approval” constituted infringe- Am., Inc., appeal. Hupp v. Siroflex of ment. Id. at 861. In that case this court 1456, 1465, 43 122 F.3d 271(a) recognized: prohibits, “Section on (Fed.Cir.1997). face, any its all patented uses of a Binding precedent invention.” Id. from In reaching infringement ver the United States Court Claims also dict, jury may have concluded that acknowledged a narrow defense to in- by offering to sell machines infringed fringement performed amusement, “for perform pat the method of the ’630 curiosity, satisfy strictly philo- idle or for precise ent. This court addressed 863; sophical inquiry.” Id. at see also Flakt, in Joy Technologies issue Inc. v. States, Pitcairn v. United Ct.Cl. Inc., USPQ2d 1378, (1976). USPQ This (Fed.Cir.1993). case, In that court in Roche thus observed that Bolar’s explained: unequivocal “The law is alleged experimental use would not even equipment perform the sale fit within the narrow confines of the al- process process is not a sale of the within experimental leged exception use because 271(a).” meaning Accordingly, Id. “in particular guise use of ‘scienti- mere offer to sell a machine such as SEC’s ” “definite, inquiry’ cognizable, fic had cannot serve as the sole basis for purposes.” insubstantial commercial claimed method. Roche, 733 F.2d at 863. However, the district court had other bas case, hiring In this SEC’s acts of Drs. deny es on which to SEC’s motion for Rosenberger, Davis and and the doctors’ JMOL, concluding that there was substan injecting with vaccine eggs acts cannot be support jury’s finding tial evidence to experimental deemed use or de minimis. patent. infringed that SEC *7 While SEC tries to cloak these tests guise inquiry, of scientific that alone can- jury The evidence on also heard not immunize its acts. The district court performed by the tests SEC and its on the it that determined record before per that agents. SEC contends the tests performed expressly for SEC tests by Rosenberger formed Drs. Davis and did purposes. chief com- commercial infringe they because were scientific purpose to demonstrate to its mercial was experiments and did not result in the sale potential customers thе usefulness of the machines, of and therefore were either injection performed by methods its in ovo minimis, merely exempt de under the machines. Just because SEC was ‍​‌‌​‌​‌​​​‌‌‌‌‌​‌‌​‌​‌​​​‌​‌‌​‌‌​‌​​​​​​​​‌‌‌​‌​‍unsuc- experimental exception. use selling machines does not cessful its upon infringement immunity confer SEC exper- This court has construed both the infringing its acts. This court there- exceptions imental use and de minimis court’s denial of fore affirms district Prods., very narrowly. Roche Inc. v. See infringement. JMOL on Co., 858, 863, Pharm. 733 F.2d 221 Bolar (Fed.Cir.1984) 937, USPQ (holding 940 C. exper- that courts should not “construe the broadly jury rule to allow a Embrex direct imental use so as awarded $500,000. of This court reviews guise damages violation of the laws of 1350 pay- or milestone as flat fees process, such by a dis- damages awarded

the amount pre-commercialization evidence, the case of and a ments in trict court for substantial case, record does not In this reaching the licenses. method court’s district compute evidence supply sufficient of discretion. for an abuse damages 1368, by section royalty as Valves, required Dray, v. reasonable Inc. (Fed.Cir.2000). Thеrefore, 1834, vacates the this 1837 284. U.S.P.Q.2d 64 $500,000 damages and sufficiency of in direct Here, challenges the award of SEC $500,000 award. for determi- underlying remands to district evidence royalty for SEC’s a reasonable

nation of above, re the sole noted method. patented As uses of the infringing district evidentiary basis for the maining is the test court’s D. Rosen by Drs. Davis and

ing performed paten entitles a Act berger. The Patent contends that appeal, On compensate damages sufficient tee to reverse the district should this court than in no event less but infringement, and trеble on willfulness court’s decision infring for the actual royalty a reasonable court used because the district process. See 35 patented ing use of the trial, At jury instruction. improper (1994). proper proof, § With U.S.C. will jury that court instructed district compen properly profits damages can lost by preponder proved be fulness could Trell patentee’s losses. See sate for the whereas, evidence, this court ance of the 1443, 1445, F.2d Corp., 912 Elecs. Marlee convincing evi proof by clear and requires (Fed.Cir.1990). 1059, 1061 USPQ2d Communications, See Comark dence. Corp., 156 F.3d Inc. v. Harris that case, court found In (Fed.Cir.1998). USPQ2d money several potential on Embrex lost However, jury in addressing the before $500,000 was suffi- sales and found issue, court must first decide struction lost sales. compensate for those cient to appeal preserved right whether SEC above, because as discussed object to the SEC did not issue. may prac- used to be sale of devices trial. timely during in a fashion instruction infringe cannot method patented tice a rights proce is a appeal Preservation infringеment, direct proof without issue, court looks to for which this dural cannot sell its machines SEC’s offers to this case regional the law of the circuit—in support for a evidentiary supply adequate Midwest Indus. the Fourth Circuit. See compensatory damage award. Trailers, Inc., Inc., v. Karavan (Fed. in only cognizable Because Cir.1999) (en part) banc relevant testing and is the fringement this case *8 (“[W]ith we respect nonpatent to issues to were not shown cause those tests the circuit in apply the of generally law Embrex, va this profits loss of to sits.”); Advаnced district court which the $500,000 award of cates the court’s district Inc., Gang v. Bao Wu Systems, Display However, in under damages. direct Kent, “in no loses § event” U.S.C. Embrex (“Because (Fed.Cir.2000) objection to royalty for entitlement to a reasonable procedural jury instruction involves Royalties are ordi tests. infringing this intimately related to matter that is not upon the sales of a narily computed based look to jurisdiction, we exclusive However, court’s patented product process. or ascertain the circuit law to the regional to com parties may other choose methods comply with the necessary requirements to may pay pute that a licensee the amount rule.”). appeal allows The Fourth Circuit product right patented for the to use a agreement, in the of terms of the such faulty jury i]f instructions absence of only plain by in the case of violation is determined this court to timely objection faith, in Community good Health be other than dam- Rice said error. See (4th Cir.2000). Ass’n, ages shall be trebled and SEC/Bounds Therefore, costs, prevail required pay must show that shаll be in- SEC occurred, cluding attorneys’ that the error was fees. “an error error affected his sub- plain, and that the Agreement jury, Settlement at 3. appellant] Even if rights.... [the stantial verdict, special that found SEC acted requirements, we will exer- satisfies these good without faith and that Embrex de- only to correct the error cise our discretion attorney served fees and costs. Because in a if failure to do so would result miscar- replete record with evidence that riage justice.” of United States v. Jen- supports jury’s that SEC (4th Cir.1998) 1006, 1008 nings, 160 F.3d faith, agreement breached the in bad omitted). (internal quotations court affirms the district court’s award of attorney fees accordance with the terms agrees This court with SEC that the agreement. error occurred and that the error was plain. because the record shows Regarding independent the section 285 after infringed that SEC award, attorney basis for the fee Embrex notice, prior litigation, and an substantial right ap- counters that SEC waived its agreement settlement that unambiguous peal faulty jury instruction on willful- precluded infringement, further this court object ness because it failed to to that jury that would have concludes trial, instruction at and because record reached the same conclusion under either supports finding irrespec- the willfulness or the and con- preponderance clear tive of the erroneous instruction. Be- Thus, standard. does not vincing SEC that the cause SEC did not show district justice miscarriage prong meet the clear error in designating committed Therefore, plain test. this court error exceptional the case or abused its discre- district court’s willfulness find- affirms the fees, attorney setting tion the amount ing. affirms the district court’s attor-

ney fee award.

E. F. argues the district court attorney Embrex fees. awarding erred appeals the Finally, SEC district explained The district court the fee Embrex’s motion to dis grant court’s independently supported by its award was defense, challenged the miss SEC’s which exceptional case conclusion under 35 government’s grant of the exclusive license (1994) § and the settlement U.S.C. Embrex, gave in turn Embrex which the dis agreement. SEC contends infringement. Grant standing to sue for attorney to award trict court’s decision motion, the district court ing Embrex’s fees under section 285 was flawed because defense was standing determined that the based-in-part the award was on the willful by judicata, res view of precluded verdict, which was in-turn flawed be ness *9 judgment prior litigation be consent cause of an erroneous instruction. judgment parties. tween the That consent prevailed, if argument Even this the settle parties’ incorporated by reference the set stated that: agreement ment agreement. agreement That stat tlement ed, exclusive li standing “Embrex has as any agent repre- If or or SEC/Bounds patent.” the ’630 Settlement thereof is found to the censee under [breach sentative of SEC’s court’s dismissal the district 1. This court concludes at Agreement standing defense. correctly dismissed court the district by res as barred standing defense judicata. COSTS assuming that the dis- even its own costs. party Each shall bear mo- granting Embrex’s trict court erred AFFIRMED-IN-PART, VACATED- dismiss, concludes that this court tion to IN-PART, and REMANDED. ‍​‌‌​‌​‌​​​‌‌‌‌‌​‌‌​‌​‌​​​‌​‌‌​‌‌​‌​​​​​​​​‌‌‌​‌​‍fully litigated have been the same issues court’s Before the district ease. another ease, in this filed SEC entry judgment Judge, concurring. RADER, Circuit District Court for States suit the United conclusions on joining the court’s While the Maryland, challenging the District of because, issues, separately I write all license of the exclusive grant government’s Patent Act leaves no my judgment, to Embrex. patent under the ’630 de minimis experimental room States, Corp. v. United Eng’g No. Service infringement. Because use excuses 1999). (D.Md. In Mar. CCB-97-833 preclude right Act Patent confers case, original challenged the SEC use,” “use,” room re- no not “substantial to Embrex as of the exclusive license grant in the law for a de minimis excuse. mains amendments there- subsequent as the

well irrelevant Similarly, because intent opinion, thirty-page In reasoned to. a well experimental use infringement, an Maryland district addressed infringe- excuse cannot survive. When assertions, rul- disposed of each of SEC’s wholly minimal or proven ment is either every on issue. Because ing against SEC non-commercial, damage computation opportunity full fair has had a SEC provides flexibility full for courts process once, standing issue at least litigate the (or perhaps any) awards preclude large judgment disturb the this court will not infringements. for minimal district court dismiss- the North Carolina ing standing defense.

I. III. affirms the district court’s This court de minimis experi denial of SEC’s This court concludes excuses, but I read the Patent mental use correctly construed the claims of altogether. excuses preclude Act to these affirms-in-part This patent. essentially an affirmative de asserts court’s denial of SEC’s motion district fense, plea on the combining based for JMOL on the verdicts activity infringing quantum amount or supports substantial evidence because minimis) plea with a based on {de jury’s verdict that the Dаvis and Rosen- infringing intent activi character or court also re- berger infringe. tests This use). (experimental Although courts ty because, law, verses-in-part as a matter of separate these occasionally have addressed infringe an offer to sell a device cannot one, see, e.g., if were they excuses as patent without evidence of the de- method States, USPQ Douglas v. United carry vice’s actual use to out the method. (Ct. Trial Division Cl. 1974 WL infringe- This court vacates the award of aff'd, 1974), F.2d 364 Ct.Cl. damages, ment and remands for determi- (1975), seрarate analyses. clarity calls for royalty, nation of a reasonable but affirms court has not inception, award of findings of willfulness and the Since infringe- a little the notion that attorney Finally, this court affirms tolerated fees.

1353 grounds, rev’d on other 520 fringement.”), ac- infringement ment —de minimis —is 1040, 17, 137 L.Ed.2d 146 117 S.Ct. infringement or not infringement ceptable (1997). pronouncements These recent directly any states at The statute all. dispose prong should of the intent-based is patented invention use of a unauthorized argument. 271(a) § 35 U.S.C. infringement. an (1994). Thus, leeway Wamer-Jenkinson, leavеs no the statute Before this in- infringement because arguments to excuse addressed based on the charac- Rather, or intent of Roche only infringed infringement a little. ter fringer Products, Inc. v. Bolar Pharmaceutical about de concerns statute accommodates 937, Co., Inc., 858, 863, USPQ 221 damages calcula- infringement minimis (Fed.Cir.1984); 940 but see 35 U.S.C. Corp. v. United Deuterium tions. See Ltd., Glaxo, 271(e); § Novopharm, Inc. v. 624, 631, States, USPQ2d 14 19 Cl.Ct. 1568, 1257, 1562, USPQ2d (“This (1990) 1636, questions (1997) 271(e) changes § (noting be de min- any infringing use can whether Roche). Supreme the result extremely small Damages for imis. infringe- reiteration that Court’s recent minimis, but may be de infringing use under- depend ment does not on the intent degree.”). question is not a infringement conduct, infringing lying allegedly Although influencing eyes, experimen- further my precludes amount, itself, quantum, infringement defense, extraordinarily tal use even wrongful effect of conduct is or economic in Roche. Of recognized narrow form For assessment. central to course, experimental even if the use excuse reasons, have might better these vitality, slight- lingering retains some in an engage invitation to declined SEC’s implication will render the est сommercial subjective of how inherently determination use” “philosophical inquiry/experimental necessary escape infringement is little in the inapplicable, doctrine as occurs Act liability. The Patent Therefore, I con- today. court’s resolution conjecture. no such simply authorizes court’s resolution of completely cur in the case, lay I would to rest although infringement excuses permanently SEC’s II. support in the Patent Act. which find no experimental use Turning next to the excuse, any past nor neither statute any rea

Supreme precedent gives Court it was infringement because

son to excuse purpose or particular

committed with a intent, experimenta as for scientific such DICK, Petitioner, Ronald S. Rather, the Su curiosity. or idle tion v. recently and this court have preme Court ‍​‌‌​‌​‌​​​‌‌‌‌‌​‌‌​‌​‌​​​‌​‌‌​‌‌​‌​​​​​​​​‌‌‌​‌​‍PERSONNEL OFFICE OF to in intent is irrelevant reiterated MANAGEMENT, Warner-Jenkinson Co. fringement. See Respondent. Co., 520 U.S. Hilton Davis Chem. (1997) No. 00-3104. 137 L.Ed.2d 146 S.Ct. equiva of the doctrine of (“Application Appeals, States Court United lents, therefore, lit determining akin to is Federal Circuit. requires and neither infringement, eral 14, 2000. June intent.”); proof Hilton Davis Chem. Co. Co. 62 F.3d v. Warner-Jenkinson (Fed.Cir.

1995) (“Intent in- not an element of

Case Details

Case Name: Embrex, Inc. v. Service Engineering Corp. And Edward G. Bounds, Jr.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Jun 28, 2000
Citation: 216 F.3d 1343
Docket Number: 99-1064
Court Abbreviation: Fed. Cir.
AI-generated responses must be verified and are not legal advice.